Analysis of time to death after transplantation when transplants are only given to patients in remission

Biometrics

Volumn 52, Issue 3, 1996, Pages 1079-1086

  Stram, Daniel O ^a   Sather, Harland ^b   Wang, Letao ^b  

^a CHILDREN S ONCOLOGY GROUP   (United States)

^b NONE

Author keywords

Mantel Byar test; Proportional hazards model; Time dependent covariates

Indexed keywords

BIOINFORMATICS; DISEASES; PATIENT TREATMENT;

'CURRENT; BONE MARROW TRANSPLANTATION; CHILDHOOD CANCERS; COX'S REGRESSION MODEL; INITIAL TREATMENT; MANTEL BYAR TEST; POTENTIAL BENEFITS; PROPORTIONAL HAZARD MODELS; SURVIVAL ANALYSIS; TIME-DEPENDENT COVARIATES;

REGRESSION ANALYSIS;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DEATH; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; NEUROBLASTOMA; REMISSION; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 0029794695     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533069     Document Type: Article

References (15)

1. Begg, C., McGlave, P., Bennett, J., et al. (1984). A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia. Journal of Clinical Oncology 2, 369-378.
2. Carter, S. (1985). Adjuvant chemotherapy (letter). Journal of Clinical Oncology 3, 1154-1155.
3. Carter, S. (1986). Reply to letter to editor. Journal of Clinical Oncology 4, 260-261.
4. Chessels, J., Bailey, C., Wheeler, K., et al. (1992). Bone marrow transplantation for high risk childhood lymphoblastic leukaemia in first remission: Experience in MRC UKALL X. Lancet 340ii, 565-568.
5. Crowley, J. and Hu, M. (1977). Covariance analysis of heart transplant survival data. Journal of the American Statistical Association 72, 27-36.
6. Gail, M. H. (1972). Does cardiac transplantation prolong life? A reassessment. Annals of Internal Medicine 76, 815-817.
7. Gehan, E. A., Sullivan, M. P., Fuller, L. M., et al. (1990). The intergroup Hodgkin's disease in children: A study of stages I and II. Cancer 65, 1429-1437.
8. Goldhirsch, A., Gelber, R. D., Simes, R. J., Glasziou, P., and Coates, A. S. (1989). Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis. Journal of Clinical Oncology 7, 36-44.
9. Goodyear, M. (1986). Letter to editor. Journal of Clinical Oncology 4, 259-260.
10. Mantel, N. and Byar, D. P. (1974). Evaluation of response-time data involving transient states: An illustration using heart-transplant data. Journal of the American Statistical Society 69, 81-86.
11. Matthay, K. K., Seeger, R. C., Reynolds, C. P., et al. (1994). Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: A report from the Childrens Cancer Group. Journal of Clinical Oncology 12, 2382-2389.
12. Simon, R. and Makuch, R. W. (1984). A non-parametric graphical representation of the relationship between survival and the occurrance of an event: Application to responder versus non-responder bias (1984). Statistics in Medicine 3, 35-44.
13. Stram, D. O., Matthay, K. K., O'Leary, M., Reynolds, C. P., and Seeger, R. C. (1994). Myeloablative chemo-radiotherapy versus continued chemotherapy for high risk neuroblastoma. In Advances in Neuroblastoma Research, Volume 4, A. E. Evans, J. L. Biedler, G. M. Broudeur, G. J. D'Angio, and A. Nakagawara (eds), 287-291. New York: Wiley-Liss.
14. Turnbull, B. W., Brown, B. W., and Hu, M. (1974). Survivorship analysis of heart transplant data. Journal of the American Statistical Association 69, 74-80.
15. Zander, A., Keating, M., Dicke, K., et al. (1988). A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. Journal of Clinical Oncology 6, 1548-1557.